| Ytd | 7.42% | |
| 1y | 6.46% |
| Open | 20.53 | Prev Close | 20.61 | Low | 20.33 | High | 20.56 | Mkt Cap | 5.20B |
| Vol | 198.27K | Avg Vol | 3.10M | EPS | 0.26 | P/E | 78.25 | Forward P/E | 26.54 |
| Beta | 0.64 | Short Ratio | 8.01 | Inst. Own | 105.41% | Dividend | 1.20 | Div Yield | 5.80 |
| Ex Div Date | 08-14 | Earning | 11-04 | 50-d Avg | 20.38 | 200-d Avg | 19.81 | 1yr Est | 22.57 |
SBRA News
Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-We
Baird analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r
Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and i
Raymond James analyst David Rodgers upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperfo
Sabra Health Care REIT (NASDAQ:SBRA) lowers FY2026 FFO guidance from $1.55-$1.59 to $1.53-$1.55 vs $
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.39 per share which met the an
Baird analyst Wesley Golladay maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy
Citizens analyst Aaron Hecht maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Market Outperf
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA)
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and l
Truist Securities analyst Michael Lewis upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Hold t
Barclays analyst Richard Hightower initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) wit
Citigroup analyst Nick Joseph downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Buy to Neutral
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P
Raymond James analyst David Rodgers reinstates Sabra Health Care REIT (NASDAQ:SBRA) from Market P
Coca-Cola is Kevin Simpson's final trade; AbbVie gets upgraded and Sabra Health Care and UnitedH
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r
Cantor Fitzgerald analyst Richard Anderson maintains Sabra Health Care REIT (NASDAQ:SBRA) with a
Sabra Health Care REIT (NASDAQ:SBRA) affirms FY2026 FFO guidance from $1.55-$1.59 to $1.55-$1.59 vs
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.39 per share which beat the a
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Hol
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r
Citigroup analyst Nick Joseph maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raise
Citizens analyst Aaron Hecht maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Market Outperf
Cantor Fitzgerald analyst Richard Anderson maintains Sabra Health Care REIT (NASDAQ:SBRA) with a
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Hol
On CNBC's "Halftime Report Final Trades," experts take a look at Sabra Health Care, Apol
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe
UBS analyst Michael Goldsmith initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) with a N
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.36 per share which beat the a
Sabra Health Care REIT (NASDAQ:SBRA) narrows FY2025 FFO guidance from $1.45-1.47 to $1.46-1.47 vs $1
Sabra Health Care REIT (NASDAQ:SBRA) narrows FY2025 FFO guidance from $1.45-$1.47 to $1.46-$1.47 vs
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.36 per share which missed the
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe
Cantor Fitzgerald analyst Richard Anderson initiates coverage on Sabra Health Care REIT (NASDAQ:S
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Hol
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe
BMO Capital analyst John Kim maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Market Perform